These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27011182)

  • 1. Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer.
    Riquelme I; Letelier P; Riffo-Campos AL; Brebi P; Roa JC
    Int J Mol Sci; 2016 Mar; 17(3):424. PubMed ID: 27011182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-induced drug resistance in gastric cancer.
    Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
    Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNA in drug resistance of gastric cancer.
    Luo YJ; Huang QM; Ren Y; Liu ZL; Xu CF; Wang H; Xiao JW
    World J Gastrointest Oncol; 2019 Nov; 11(11):957-970. PubMed ID: 31798777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
    Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
    Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of microRNAs in Multidrug-Resistance Mechanisms in Gastric Cancer.
    Zeng X; Wang HY; Bai SY; Pu K; Wang YP; Zhou YN
    Curr Mol Med; 2020; 20(9):667-674. PubMed ID: 32209033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
    Matuszcak C; Haier J; Hummel R; Lindner K
    World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
    Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
    Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells.
    Russi S; Verma HK; Laurino S; Mazzone P; Storto G; Nardelli A; Zoppoli P; Calice G; La Rocca F; Sgambato A; Lucci V; Falco G; Ruggieri V
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
    Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
    J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.
    Yang W; Ma J; Zhou W; Zhou X; Cao B; Zhang H; Zhao Q; Fan D; Hong L
    Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1151-1163. PubMed ID: 28838272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer.
    Yu B; Gu D; Zhang X; Li J; Liu B; Xie J
    Oncotarget; 2017 Apr; 8(16):27412-27427. PubMed ID: 28404967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1.
    Zhang Y; Xu W; Ni P; Li A; Zhou J; Xu S
    Int J Biol Sci; 2016; 12(12):1437-1447. PubMed ID: 27994509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
    Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
    Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.
    Lu C; Shan Z; Li C; Yang L
    Biomed Pharmacother; 2017 Feb; 86():450-456. PubMed ID: 28012924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34 dysregulation in gastric cancer and gastric cancer stem cell.
    Jafari N; Abediankenari S
    Tumour Biol; 2017 May; 39(5):1010428317701652. PubMed ID: 28468587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells.
    Korourian A; Roudi R; Shariftabrizi A; Madjd Z
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1842-1847. PubMed ID: 28836853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.